Efficacy of Faricimab in Clinical Trails
Experts discuss clinical trials on the efficacy of faricimab and how they utilize this therapy in their practice.
Source: hcplive.com
Page 2 - Ehsan Rahimy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ehsan Rahimy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ehsan Rahimy Today - Breaking & Trending Today
Do GLP-1 Agonists Worsen Diabetic Retinopathy?
Patients taking glucagon-like peptide-1 agonists were more likely to progress from nonproliferative diabetic retinopathy to proliferative disease or diabetic macular edema than those who took sodium-glucose cotransporter-2 inhibitors.
Source: medscape.com
Key Findings of Protocol T Study
Experts discuss the results of Protocol T study comparing anti-vascular endothelial growth factor (Anti-VEGF) agents for the treatment of diabetic macular edema (DME).
Source: hcplive.com
Key Findings of DRCR Protocol AC Study
Experts discuss the recent DRCR Protocol AC study comparing aflibercept monotherapy vs bevacizumab first therapy for patients with diabetic macular edema (DME).
Source: hcplive.com
Geographic atrophy causes substantial disease burden in macular degeneration
NEW YORK — A retrospective study of more than 36,000 patients showed that geographic atrophy causes substantial disease burden, according to a speaker here.
Source: healio.com